Feature Requests

After February's raise in prices, my typical battery of tests/panels went up 29.1%. In the case of the Viral Infections Panel, a 100% increase in price. The minimum order amount also went up 100%, from $125 to $250. Where the hell does that leave practitioners and small business to have any kind of MEANINGFUL margins on testing to reinvest or grow their business. And no, the new tiered pricing structure simply funnels practitioners into ordering more expensive tests under the guise of getting more value for your money. That may be the case from Vibrant's perspective, but you're into the stratosphere with testing costs, regardless of the nominal value. Patients see numbers, not value, when you're talking high 3-digit, 4-digit pricing, unless they're in the ER fighting to survive or are in the top 10% of income earners. Also, Vibrant doesn't even have dedicated lab locations, adding to the cost of blood draws. Meanwhile, LabCorp via Evexia raised their phlebotomy fee from $5 to $7, yes 40%, that doesn't feel like anything. Give me a break. Last I checked, people's WAGES DIDN'T GO UP 30-100% Year-over-Year, so where do people find the extra income to cover this gap, or do we just shear and scalp everyone for their last savings? Smells of exuberant hubris with little regard to their clientele. I'll be looking into other diagnostic tools and local laboratories to people's money to better use. Perhaps other practitioners can also chime in with their opinion and patient feedback experienced... Thank you.

It would be helpful to allow items from the Cardio Zoomer to ordered individually. For example items from the Endothelial Dysfunction section, such as ADMA/SDMA, as this is very important in assessing cardiovascular health when the entire panel may not be needed.

Make it easy for providers to see what information is provided with each lab- I'm trying to see what Regenere provides to the patient and have nothing to help them understand why they would spend $400 on the test for a specialized serum. Similarly for the single gene tests- MTHFR etc- what information do we get? How does that compare with the cardio genetics report for those same genes? And what are these new NutriPoz tests? I'm not even sure I spelled that right but it's really difficult to stay up to date on what products you all are offering and what the reports look like.

The Summary list at the beginning is an extremely valuable tool.

From a clinical perspective on LPS, I’d actually prefer to see IgG and IgM reported separately rather than combined. Here’s why: if I have the individual values, I can always add them together myself to get that global snapshot. But when they’re already combined, I lose the ability to pull them apart, and that’s where the clinical nuance lives. Knowing whether someone’s LPS reactivity is predominantly IgM-driven versus IgG-driven changes how I interpret what’s happening in real time. An IgM-dominant response tells me something very different than an IgG-dominant response. One suggests an active, early-phase breach of gut barrier integrity. The other points to a chronic, sustained endotoxin exposure pattern. The research is early, but potentially those are two different clinical conversations, two different levels of urgency, and potentially two different intervention strategies, but reality is the science is so new, I think it’s too early just to combine them so we can actually see the dominance of one verse the other. When we combine them, we flatten that distinction. We get a number that says “yes, there’s immune activation to LPS,” but we lose the texture of what that activation actually looks like. And for those of us making treatment decisions based on these results, that context matters. So my ask would be to consider reporting IgG and IgM separately, and then if you want to include a combined total as an additional data point, that gives clinicians the best of both worlds. We get the granularity we need for precision decision-making, and anyone who prefers the global view still has it. I’d love to see that kind of reporting flexibility built into future iterations of the panel. It would make an already excellent test even more clinically actionable.

The old report used to report a CDC/IDSA Lyme Criteria and an Alternative Lyme Criteria but this is not included on the new report. Provider has requested this be added to the new reporting. Provider is Deidre Bloomquist - Always Growing.

Can you please add a provider filter to view the tests ordered by providers? Also, can you please somehow list the bundles and what is included? So rather than list 3 for $700 several times - can you actually lists the test within the bundle.

We draw some patient in-office. It would be nice to add an option of 'ship to clinic', in addition to 'supplied by office' or 'ship to patient'.

Dr. Bates primarily sees MS patients and would love for the Gut Zoomer to test for Eisenbergia tayi & Lachnoclostridium bacteria

It would be helpful to have amylase and lipase available.